fanta.bio Sample: CNhs11945
18010 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1462 / 18299 (8.0%) | 344 / 182990 (0.2%) | −324.0 | −324.0 | 42.50 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 2142 / 18299 (11.7%) | 634 / 182990 (0.3%) | −324.0 | −324.0 | 33.79 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 536 / 18299 (2.9%) | 183 / 182990 (0.1%) | −324.0 | −324.0 | 29.29 |
| TP53 SRX19538268 | U2OS Bone | 472 / 18299 (2.6%) | 169 / 182990 (0.1%) | −324.0 | −324.0 | 27.93 |
| TP53 SRX19538274 | U2OS Bone | 476 / 18299 (2.6%) | 171 / 182990 (0.1%) | −324.0 | −324.0 | 27.84 |
| HIF1A SRX11007095 | HK-2 Kidney | 2569 / 18299 (14.0%) | 925 / 182990 (0.5%) | −324.0 | −324.0 | 27.77 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1992 / 18299 (10.9%) | 756 / 182990 (0.4%) | −324.0 | −324.0 | 26.35 |
| TP53 SRX19538276 | U2OS Bone | 473 / 18299 (2.6%) | 187 / 182990 (0.1%) | −324.0 | −324.0 | 25.29 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2804 / 18299 (15.3%) | 1123 / 182990 (0.6%) | −324.0 | −324.0 | 24.97 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2729 / 18299 (14.9%) | 1114 / 182990 (0.6%) | −324.0 | −324.0 | 24.50 |
| SCML2 SRX644728 | 293 Kidney | 1689 / 18299 (9.2%) | 699 / 182990 (0.4%) | −324.0 | −324.0 | 24.16 |
| HIF1A SRX20663235 | HK-2 Kidney | 590 / 18299 (3.2%) | 254 / 182990 (0.1%) | −324.0 | −324.0 | 23.23 |
| FOXP1 SRX736067 | LNCAP Prostate | 2332 / 18299 (12.7%) | 1046 / 182990 (0.6%) | −324.0 | −324.0 | 22.29 |
| TP53 SRX19538279 | Osteoblasts Bone | 576 / 18299 (3.1%) | 280 / 182990 (0.2%) | −324.0 | −324.0 | 20.57 |
| MYH11 SRX265221 | ME-1 Blood | 1018 / 18299 (5.6%) | 592 / 182990 (0.3%) | −324.0 | −324.0 | 17.20 |
| MED1 SRX9419945 | BT-474 Breast | 4336 / 18299 (23.7%) | 2688 / 182990 (1.5%) | −324.0 | −324.0 | 16.13 |
| MED1 SRX9419944 | BT-474 Breast | 4213 / 18299 (23.0%) | 2669 / 182990 (1.5%) | −324.0 | −324.0 | 15.78 |
| BRD4 SRX9419936 | BT-474 Breast | 4408 / 18299 (24.1%) | 2845 / 182990 (1.6%) | −324.0 | −324.0 | 15.49 |
| BRD4 SRX9419935 | BT-474 Breast | 4271 / 18299 (23.3%) | 2777 / 182990 (1.5%) | −324.0 | −324.0 | 15.38 |
| BRD4 SRX9419938 | BT-474 Breast | 4355 / 18299 (23.8%) | 2833 / 182990 (1.5%) | −324.0 | −324.0 | 15.37 |
| MED1 SRX9419946 | BT-474 Breast | 4381 / 18299 (23.9%) | 2878 / 182990 (1.6%) | −324.0 | −324.0 | 15.22 |
| MED1 SRX9419947 | BT-474 Breast | 4272 / 18299 (23.3%) | 2813 / 182990 (1.5%) | −324.0 | −324.0 | 15.19 |
| BRD4 SRX9419937 | BT-474 Breast | 4239 / 18299 (23.2%) | 2811 / 182990 (1.5%) | −324.0 | −324.0 | 15.08 |
| EZH2 SRX2146136 | LNCAP Prostate | 9546 / 18299 (52.2%) | 8127 / 182990 (4.4%) | −324.0 | −324.0 | 11.75 |
| BRD4 SRX736201 | 90-8TL Neural | 7301 / 18299 (39.9%) | 6611 / 182990 (3.6%) | −324.0 | −324.0 | 11.04 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 873 / 18299 (4.8%) | 989 / 182990 (0.5%) | −324.0 | −324.0 | 8.83 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 794 / 18299 (4.3%) | 940 / 182990 (0.5%) | −324.0 | −324.0 | 8.45 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2148 / 18299 (11.7%) | 2798 / 182990 (1.5%) | −324.0 | −324.0 | 7.68 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1578 / 18299 (8.6%) | 3896 / 182990 (2.1%) | −324.0 | −324.0 | 4.05 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1870 / 18299 (10.2%) | 5450 / 182990 (3.0%) | −324.0 | −324.0 | 3.43 |
| Epitope tags SRX10549776 | K-562 Blood | 1833 / 18299 (10.0%) | 5414 / 182990 (3.0%) | −324.0 | −324.0 | 3.39 |
| KAT7 SRX101303 | RKO Digestive tract | 1752 / 18299 (9.6%) | 5403 / 182990 (3.0%) | −324.0 | −324.0 | 3.24 |
| AGO2 SRX4708039 | Hep G2 Liver | 2376 / 18299 (13.0%) | 7970 / 182990 (4.4%) | −324.0 | −324.0 | 2.98 |
| 5-mC SRX882970 | LNCAP Prostate | 3434 / 18299 (18.8%) | 16175 / 182990 (8.8%) | −324.0 | −324.0 | 2.12 |
| 5-mC SRX882968 | LNCAP Prostate | 3378 / 18299 (18.5%) | 16052 / 182990 (8.8%) | −324.0 | −324.0 | 2.10 |
| PBX4 SRX2731658 | PC-3 Prostate | 906 / 18299 (5.0%) | 28879 / 182990 (15.8%) | −324.0 | −324.0 | 0.31 |
| FOS SRX150477 | MCF 10A Breast | 633 / 18299 (3.5%) | 21493 / 182990 (11.7%) | −324.0 | −324.0 | 0.29 |
| YAP1 SRX757325 | H2052 Lung | 632 / 18299 (3.5%) | 22378 / 182990 (12.2%) | −324.0 | −324.0 | 0.28 |
| YAP1 SRX757326 | H2052 Lung | 548 / 18299 (3.0%) | 19882 / 182990 (10.9%) | −324.0 | −324.0 | 0.28 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 662 / 18299 (3.6%) | 681 / 182990 (0.4%) | −318.8 | −315.9 | 9.72 |
| FOS SRX150478 | MCF 10A Breast | 689 / 18299 (3.8%) | 22034 / 182990 (12.0%) | −317.4 | −314.5 | 0.31 |
| BRD1 SRX286203 | RKO Digestive tract | 1507 / 18299 (8.2%) | 4361 / 182990 (2.4%) | −312.8 | −309.9 | 3.46 |
| TP53 SRX19538267 | U2OS Bone | 428 / 18299 (2.3%) | 149 / 182990 (0.1%) | −312.0 | −309.1 | 28.72 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 735 / 18299 (4.0%) | 981 / 182990 (0.5%) | −303.2 | −300.4 | 7.49 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 649 / 18299 (3.5%) | 20800 / 182990 (11.4%) | −298.9 | −296.0 | 0.31 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1015 / 18299 (5.5%) | 26407 / 182990 (14.4%) | −298.0 | −295.1 | 0.38 |
| TP53 SRX19538280 | Osteoblasts Bone | 451 / 18299 (2.5%) | 220 / 182990 (0.1%) | −297.9 | −295.0 | 20.50 |
| BRPF3 SRX796084 | RKO Digestive tract | 1848 / 18299 (10.1%) | 6473 / 182990 (3.5%) | −297.0 | −294.2 | 2.85 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 684 / 18299 (3.7%) | 21248 / 182990 (11.6%) | −295.3 | −292.4 | 0.32 |
| SS18 SRX3468047 | Fibroblasts Others | 728 / 18299 (4.0%) | 21877 / 182990 (12.0%) | −293.0 | −290.2 | 0.33 |
| TP53 SRX19538275 | U2OS Bone | 423 / 18299 (2.3%) | 178 / 182990 (0.1%) | −292.5 | −289.7 | 23.76 |
| TP53 SRX19538273 | U2OS Bone | 411 / 18299 (2.2%) | 159 / 182990 (0.1%) | −291.2 | −288.4 | 25.85 |
| TP53 SRX19538281 | Osteoblasts Bone | 485 / 18299 (2.7%) | 313 / 182990 (0.2%) | −289.7 | −286.9 | 15.50 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 684 / 18299 (3.7%) | 21065 / 182990 (11.5%) | −289.6 | −286.9 | 0.32 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 638 / 18299 (3.5%) | 756 / 182990 (0.4%) | −283.3 | −280.5 | 8.44 |
| FOXA1 SRX4815197 | MCF-7 Breast | 732 / 18299 (4.0%) | 21620 / 182990 (11.8%) | −283.2 | −280.5 | 0.34 |
| BRPF3 SRX796085 | RKO Digestive tract | 1336 / 18299 (7.3%) | 3793 / 182990 (2.1%) | −282.7 | −280.0 | 3.52 |
| BRPF3 SRX796086 | RKO Digestive tract | 1758 / 18299 (9.6%) | 6173 / 182990 (3.4%) | −280.8 | −278.0 | 2.85 |
| RUNX1 SRX2513054 | 293 Kidney | 3631 / 18299 (19.8%) | 18997 / 182990 (10.4%) | −278.5 | −275.7 | 1.91 |
| AR SRX10820653 | LNCAP Prostate | 414 / 18299 (2.3%) | 191 / 182990 (0.1%) | −278.3 | −275.6 | 21.68 |
| YAP1 SRX5718140 | 293 Kidney | 473 / 18299 (2.6%) | 17191 / 182990 (9.4%) | −277.2 | −274.5 | 0.28 |
| TCF12 SRX190356 | SK-N-SH Neural | 827 / 18299 (4.5%) | 22793 / 182990 (12.5%) | −274.5 | −271.8 | 0.36 |
| GATA3 SRX190194 | SK-N-SH Neural | 707 / 18299 (3.9%) | 20936 / 182990 (11.4%) | −274.4 | −271.7 | 0.34 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 562 / 18299 (3.1%) | 18493 / 182990 (10.1%) | −271.0 | −268.3 | 0.30 |
| FOS SRX4192880 | MCF 10A Breast | 502 / 18299 (2.7%) | 17486 / 182990 (9.6%) | −270.7 | −268.0 | 0.29 |
| AGO2 SRX6783957 | Hep G2 Liver | 1493 / 18299 (8.2%) | 4793 / 182990 (2.6%) | −270.0 | −267.3 | 3.11 |
| AGO2 SRX6783958 | Hep G2 Liver | 1472 / 18299 (8.0%) | 4679 / 182990 (2.6%) | −269.8 | −267.1 | 3.15 |
| FOXA1 SRX176863 | MCF-7 Breast | 337 / 18299 (1.8%) | 14530 / 182990 (7.9%) | −269.0 | −266.3 | 0.23 |
| 5-mC SRX882965 | LNCAP Prostate | 2708 / 18299 (14.8%) | 12548 / 182990 (6.9%) | −268.3 | −265.6 | 2.16 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2386 / 18299 (13.0%) | 10365 / 182990 (5.7%) | −267.6 | −264.9 | 2.30 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 689 / 18299 (3.8%) | 20360 / 182990 (11.1%) | −265.6 | −262.9 | 0.34 |
| FOXA1 SRX176862 | MCF-7 Breast | 383 / 18299 (2.1%) | 15247 / 182990 (8.3%) | −265.0 | −262.3 | 0.25 |
| FOXA1 SRX3931044 | MCF-7 Breast | 672 / 18299 (3.7%) | 20011 / 182990 (10.9%) | −263.1 | −260.4 | 0.34 |
| ESR1 SRX7624157 | MCF-7 Breast | 838 / 18299 (4.6%) | 22507 / 182990 (12.3%) | −261.3 | −258.6 | 0.37 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1107 / 18299 (6.0%) | 26278 / 182990 (14.4%) | −256.7 | −254.0 | 0.42 |
| TP53 SRX19538269 | U2OS Bone | 506 / 18299 (2.8%) | 471 / 182990 (0.3%) | −256.5 | −253.8 | 10.74 |
| IRF3 SRX11453858 | Hep G2 Liver | 332 / 18299 (1.8%) | 91 / 182990 (0.0%) | −256.3 | −253.7 | 36.48 |
| BRD4 SRX736204 | 90-8TL Neural | 1129 / 18299 (6.2%) | 3037 / 182990 (1.7%) | −253.7 | −251.1 | 3.72 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 194 / 18299 (1.1%) | 11234 / 182990 (6.1%) | −251.0 | −248.4 | 0.17 |
| FOS SRX150517 | MCF 10A Breast | 537 / 18299 (2.9%) | 17389 / 182990 (9.5%) | −249.3 | −246.7 | 0.31 |
| GATA3 SRX190239 | MCF-7 Breast | 455 / 18299 (2.5%) | 16016 / 182990 (8.8%) | −249.1 | −246.5 | 0.28 |
| FOXA1 SRX1161177 | MCF-7 Breast | 295 / 18299 (1.6%) | 13112 / 182990 (7.2%) | −247.2 | −244.6 | 0.22 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1116 / 18299 (6.1%) | 26028 / 182990 (14.2%) | −246.6 | −244.0 | 0.43 |
| AR SRX10820651 | LNCAP Prostate | 429 / 18299 (2.3%) | 305 / 182990 (0.2%) | −246.2 | −243.6 | 14.07 |
| ESR1 SRX7624156 | MCF-7 Breast | 513 / 18299 (2.8%) | 16888 / 182990 (9.2%) | −246.0 | −243.5 | 0.30 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 813 / 18299 (4.4%) | 21482 / 182990 (11.7%) | −242.7 | −240.1 | 0.38 |
| TP53 SRX19538270 | U2OS Bone | 485 / 18299 (2.7%) | 467 / 182990 (0.3%) | −241.5 | −239.0 | 10.39 |
| SMARCA2 SRX8119677 | MeT-5A Others | 506 / 18299 (2.8%) | 16613 / 182990 (9.1%) | −241.0 | −238.5 | 0.30 |
| ESR1 SRX371478 | MCF-7 Breast | 415 / 18299 (2.3%) | 15022 / 182990 (8.2%) | −239.3 | −236.7 | 0.28 |
| ESR1 SRX20282961 | MCF-7 Breast | 401 / 18299 (2.2%) | 14752 / 182990 (8.1%) | −238.3 | −235.8 | 0.27 |
| TLE3 SRX4815191 | MCF-7 Breast | 284 / 18299 (1.6%) | 12634 / 182990 (6.9%) | −238.1 | −235.5 | 0.22 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 449 / 18299 (2.5%) | 15564 / 182990 (8.5%) | −238.0 | −235.4 | 0.29 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 553 / 18299 (3.0%) | 17248 / 182990 (9.4%) | −236.9 | −234.3 | 0.32 |
| ING5 SRX286202 | RKO Digestive tract | 1532 / 18299 (8.4%) | 5484 / 182990 (3.0%) | −236.0 | −233.4 | 2.79 |
| ESR1 SRX371469 | MCF-7 Breast | 328 / 18299 (1.8%) | 13381 / 182990 (7.3%) | −235.9 | −233.3 | 0.25 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 704 / 18299 (3.8%) | 19568 / 182990 (10.7%) | −235.2 | −232.7 | 0.36 |
| EP300 SRX2671813 | Fibroblasts Others | 225 / 18299 (1.2%) | 11404 / 182990 (6.2%) | −234.7 | −232.2 | 0.20 |
| FOS SRX150476 | MCF 10A Breast | 568 / 18299 (3.1%) | 17409 / 182990 (9.5%) | −234.5 | −231.9 | 0.33 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 368 / 18299 (2.0%) | 14019 / 182990 (7.7%) | −233.3 | −230.8 | 0.26 |
| FOXA1 SRX371483 | MCF-7 Breast | 369 / 18299 (2.0%) | 13964 / 182990 (7.6%) | −231.0 | −228.5 | 0.26 |
| JUN SRX6582171 | GM07492 Others | 638 / 18299 (3.5%) | 18366 / 182990 (10.0%) | −230.0 | −227.5 | 0.35 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1254 / 18299 (6.9%) | 27315 / 182990 (14.9%) | −229.9 | −227.4 | 0.46 |
| FOXA1 SRX371481 | MCF-7 Breast | 345 / 18299 (1.9%) | 13458 / 182990 (7.4%) | −228.3 | −225.8 | 0.26 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 476 / 18299 (2.6%) | 15692 / 182990 (8.6%) | −227.9 | −225.4 | 0.30 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 372 / 18299 (2.0%) | 13914 / 182990 (7.6%) | −227.7 | −225.2 | 0.27 |
| FOXA1 SRX1161173 | MCF-7 Breast | 239 / 18299 (1.3%) | 11456 / 182990 (6.3%) | −227.1 | −224.6 | 0.21 |
| MAU2 SRX15710550 | Fibroblasts Others | 536 / 18299 (2.9%) | 16644 / 182990 (9.1%) | −227.0 | −224.5 | 0.32 |
| ESR1 SRX371476 | MCF-7 Breast | 218 / 18299 (1.2%) | 11040 / 182990 (6.0%) | −226.9 | −224.4 | 0.20 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1355 / 18299 (7.4%) | 28566 / 182990 (15.6%) | −226.7 | −224.2 | 0.47 |
| EP300 SRX2194266 | SUM 159PT Breast | 572 / 18299 (3.1%) | 17198 / 182990 (9.4%) | −226.2 | −223.7 | 0.33 |
| FOXA1 SRX371482 | MCF-7 Breast | 493 / 18299 (2.7%) | 15915 / 182990 (8.7%) | −226.1 | −223.7 | 0.31 |
| FOXA1 SRX1161176 | MCF-7 Breast | 306 / 18299 (1.7%) | 12646 / 182990 (6.9%) | −224.7 | −222.2 | 0.24 |
| FOXA1 SRX1161175 | MCF-7 Breast | 222 / 18299 (1.2%) | 11059 / 182990 (6.0%) | −224.7 | −222.2 | 0.20 |
| NR3C1 SRX2609664 | HASM2 Lung | 449 / 18299 (2.5%) | 15134 / 182990 (8.3%) | −224.6 | −222.1 | 0.30 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 752 / 18299 (4.1%) | 19900 / 182990 (10.9%) | −223.8 | −221.3 | 0.38 |
| CIC SRX13262055 | Astrocytes Neural | 3285 / 18299 (18.0%) | 17866 / 182990 (9.8%) | −223.3 | −220.8 | 1.84 |
| PBX3 SRX190343 | SK-N-SH Neural | 711 / 18299 (3.9%) | 19252 / 182990 (10.5%) | −223.0 | −220.6 | 0.37 |
| JUN SRX17561461 | LPS141 Adipocyte | 472 / 18299 (2.6%) | 15451 / 182990 (8.4%) | −222.5 | −220.0 | 0.31 |
| Epitope tags DRX443510 | 293 Kidney | 1663 / 18299 (9.1%) | 6500 / 182990 (3.6%) | −222.1 | −219.7 | 2.56 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 488 / 18299 (2.7%) | 15694 / 182990 (8.6%) | −221.9 | −219.5 | 0.31 |
| ESR1 SRX20282960 | MCF-7 Breast | 384 / 18299 (2.1%) | 13924 / 182990 (7.6%) | −221.2 | −218.8 | 0.28 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 304 / 18299 (1.7%) | 12502 / 182990 (6.8%) | −221.2 | −218.7 | 0.24 |
| TP53 SRX19538282 | Osteoblasts Bone | 406 / 18299 (2.2%) | 326 / 182990 (0.2%) | −220.9 | −218.4 | 12.45 |
| ESR1 SRX176860 | MCF-7 Breast | 577 / 18299 (3.2%) | 17081 / 182990 (9.3%) | −220.4 | −218.0 | 0.34 |
| MEAF6 DRX234811 | 293 Kidney | 1887 / 18299 (10.3%) | 7974 / 182990 (4.4%) | −219.9 | −217.4 | 2.37 |
| AR SRX1067071 | LHSAR Prostate | 685 / 18299 (3.7%) | 18723 / 182990 (10.2%) | −219.3 | −216.8 | 0.37 |
| ESR1 SRX4367193 | MCF-7 Breast | 1171 / 18299 (6.4%) | 25751 / 182990 (14.1%) | −219.1 | −216.6 | 0.45 |
| IRF3 SRX11453861 | Hep G2 Liver | 288 / 18299 (1.6%) | 87 / 182990 (0.0%) | −217.4 | −215.0 | 33.10 |
| JUNB SRX8488088 | SUM 229PE Breast | 682 / 18299 (3.7%) | 18586 / 182990 (10.2%) | −216.6 | −214.2 | 0.37 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 939 / 18299 (5.1%) | 22390 / 182990 (12.2%) | −216.5 | −214.1 | 0.42 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1141 / 18299 (6.2%) | 25238 / 182990 (13.8%) | −216.5 | −214.1 | 0.45 |
| ESR1 SRX176861 | MCF-7 Breast | 584 / 18299 (3.2%) | 17043 / 182990 (9.3%) | −216.0 | −213.6 | 0.34 |
| JUNB SRX8488073 | SUM 229PE Breast | 647 / 18299 (3.5%) | 18014 / 182990 (9.8%) | −215.6 | −213.2 | 0.36 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 300 / 18299 (1.6%) | 111 / 182990 (0.1%) | −215.1 | −212.7 | 27.03 |
| MEAF6 DRX300417 | 293 Kidney | 1728 / 18299 (9.4%) | 7033 / 182990 (3.8%) | −215.0 | −212.6 | 2.46 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 436 / 18299 (2.4%) | 14590 / 182990 (8.0%) | −214.4 | −212.0 | 0.30 |
| FOS SRX4192879 | MCF 10A Breast | 383 / 18299 (2.1%) | 13688 / 182990 (7.5%) | −214.3 | −211.9 | 0.28 |
| FOXA1 SRX100454 | T-47D Breast | 441 / 18299 (2.4%) | 14669 / 182990 (8.0%) | −214.3 | −211.9 | 0.30 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 238 / 18299 (1.3%) | 11036 / 182990 (6.0%) | −213.2 | −210.8 | 0.22 |
| ESR1 SRX371471 | ZR-75-1 Breast | 370 / 18299 (2.0%) | 13394 / 182990 (7.3%) | −212.2 | −209.8 | 0.28 |
| RAC1 SRX10365541 | MCF-7 Breast | 150 / 18299 (0.8%) | 9216 / 182990 (5.0%) | −211.5 | −209.1 | 0.16 |
| JUND SRX190357 | SK-N-SH Neural | 420 / 18299 (2.3%) | 14222 / 182990 (7.8%) | −211.4 | −209.0 | 0.30 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 439 / 18299 (2.4%) | 14533 / 182990 (7.9%) | −211.0 | −208.7 | 0.30 |
| NR3C1 SRX2609662 | HASM2 Lung | 395 / 18299 (2.2%) | 13772 / 182990 (7.5%) | −210.5 | −208.2 | 0.29 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 512 / 18299 (2.8%) | 15711 / 182990 (8.6%) | −210.4 | −208.1 | 0.33 |
| ESR1 SRX371470 | ZR-75-1 Breast | 304 / 18299 (1.7%) | 12160 / 182990 (6.6%) | −209.9 | −207.6 | 0.25 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 593 / 18299 (3.2%) | 979 / 182990 (0.5%) | −209.9 | −207.6 | 6.06 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 575 / 18299 (3.1%) | 16695 / 182990 (9.1%) | −209.9 | −207.5 | 0.34 |
| GATA3 SRX5057632 | MCF-7 Breast | 203 / 18299 (1.1%) | 10258 / 182990 (5.6%) | −209.9 | −207.5 | 0.20 |
| ESR1 SRX371479 | MCF-7 Breast | 319 / 18299 (1.7%) | 12427 / 182990 (6.8%) | −209.8 | −207.5 | 0.26 |
| Epitope tags SRX10549778 | K-562 Blood | 1267 / 18299 (6.9%) | 4307 / 182990 (2.4%) | −209.8 | −207.4 | 2.94 |
| FOXL2 SRX6957431 | KGN Gonad | 824 / 18299 (4.5%) | 20457 / 182990 (11.2%) | −209.6 | −207.2 | 0.40 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 698 / 18299 (3.8%) | 1410 / 182990 (0.8%) | −209.0 | −206.7 | 4.95 |
| ESR1 SRX194572 | MCF-7 Breast | 201 / 18299 (1.1%) | 10178 / 182990 (5.6%) | −208.5 | −206.2 | 0.20 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 333 / 18299 (1.8%) | 12634 / 182990 (6.9%) | −208.5 | −206.1 | 0.26 |
| ESR1 SRX20282939 | MCF-7 Breast | 404 / 18299 (2.2%) | 13860 / 182990 (7.6%) | −208.5 | −206.1 | 0.29 |
| TP53 SRX396254 | Fibroblasts Others | 1009 / 18299 (5.5%) | 2904 / 182990 (1.6%) | −208.4 | −206.1 | 3.47 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1084 / 18299 (5.9%) | 24126 / 182990 (13.2%) | −208.3 | −206.0 | 0.45 |
| SMARCA4 SRX5212362 | Mel270 Others | 608 / 18299 (3.3%) | 17151 / 182990 (9.4%) | −208.2 | −205.9 | 0.35 |
| CEBPB SRX150632 | HeLa Uterus | 810 / 18299 (4.4%) | 20201 / 182990 (11.0%) | −208.1 | −205.8 | 0.40 |
| NR3C1 SRX2609659 | HASM2 Lung | 392 / 18299 (2.1%) | 13646 / 182990 (7.5%) | −208.1 | −205.8 | 0.29 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 295 / 18299 (1.6%) | 11939 / 182990 (6.5%) | −207.9 | −205.6 | 0.25 |
| STAT5B SRX831881 | CD8+ T cells Blood | 309 / 18299 (1.7%) | 143 / 182990 (0.1%) | −207.5 | −205.2 | 21.61 |
| ESR1 SRX1531791 | MCF-7 Breast | 333 / 18299 (1.8%) | 12600 / 182990 (6.9%) | −207.4 | −205.1 | 0.26 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 306 / 18299 (1.7%) | 12114 / 182990 (6.6%) | −207.2 | −204.9 | 0.25 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 615 / 18299 (3.4%) | 17214 / 182990 (9.4%) | −206.9 | −204.6 | 0.36 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 330 / 18299 (1.8%) | 12512 / 182990 (6.8%) | −206.2 | −203.9 | 0.26 |
| NR3C1 SRX2609665 | HASM2 Lung | 367 / 18299 (2.0%) | 13155 / 182990 (7.2%) | −206.2 | −203.9 | 0.28 |
| BMI1 SRX644729 | 293 Kidney | 295 / 18299 (1.6%) | 120 / 182990 (0.1%) | −206.0 | −203.7 | 24.58 |
| AR SRX1067070 | LHSAR Prostate | 897 / 18299 (4.9%) | 21354 / 182990 (11.7%) | −205.1 | −202.8 | 0.42 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1063 / 18299 (5.8%) | 23691 / 182990 (12.9%) | −204.7 | −202.4 | 0.45 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 306 / 18299 (1.7%) | 12037 / 182990 (6.6%) | −204.7 | −202.4 | 0.25 |
| ESR1 SRX371468 | MCF-7 Breast | 209 / 18299 (1.1%) | 10223 / 182990 (5.6%) | −204.7 | −202.4 | 0.20 |
| FOXA1 SRX3923514 | MCF-7 Breast | 351 / 18299 (1.9%) | 12826 / 182990 (7.0%) | −204.5 | −202.2 | 0.27 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1052 / 18299 (5.7%) | 23522 / 182990 (12.9%) | −204.3 | −202.0 | 0.45 |
| GATA3 SRX176864 | MCF-7 Breast | 245 / 18299 (1.3%) | 10899 / 182990 (6.0%) | −204.1 | −201.8 | 0.22 |
| FOXA1 SRX1787653 | MCF-7 Breast | 271 / 18299 (1.5%) | 11383 / 182990 (6.2%) | −204.1 | −201.8 | 0.24 |
| TP53 SRX19538271 | U2OS Bone | 673 / 18299 (3.7%) | 1342 / 182990 (0.7%) | −203.8 | −201.5 | 5.01 |
| FOSL2 SRX190296 | SK-N-SH Neural | 464 / 18299 (2.5%) | 14694 / 182990 (8.0%) | −203.4 | −201.1 | 0.32 |
| FOXA1 SRX3931043 | MCF-7 Breast | 352 / 18299 (1.9%) | 12801 / 182990 (7.0%) | −203.1 | −200.9 | 0.27 |
| WWTR1 SRX10119367 | MCF 10A Breast | 396 / 18299 (2.2%) | 13548 / 182990 (7.4%) | −202.9 | −200.6 | 0.29 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1897 / 18299 (10.4%) | 8368 / 182990 (4.6%) | −202.9 | −200.6 | 2.27 |
| FOXA1 SRX1161174 | MCF-7 Breast | 361 / 18299 (2.0%) | 12941 / 182990 (7.1%) | −202.6 | −200.4 | 0.28 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 682 / 18299 (3.7%) | 18086 / 182990 (9.9%) | −202.4 | −200.1 | 0.38 |
| VGLL1 SRX24602130 | BT-20 Breast | 356 / 18299 (1.9%) | 12843 / 182990 (7.0%) | −202.2 | −200.0 | 0.28 |
| RAC1 SRX10365543 | MCF-7 Breast | 160 / 18299 (0.9%) | 9159 / 182990 (5.0%) | −201.9 | −199.7 | 0.17 |
| ESR1 SRX194569 | MCF-7 Breast | 379 / 18299 (2.1%) | 13215 / 182990 (7.2%) | −201.5 | −199.3 | 0.29 |
| SMARCA4 SRX5212366 | Mel270 Others | 473 / 18299 (2.6%) | 14758 / 182990 (8.1%) | −200.8 | −198.6 | 0.32 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 637 / 18299 (3.5%) | 17335 / 182990 (9.5%) | −200.6 | −198.4 | 0.37 |
| PRRX1 SRX15235713 | Hs 578T Breast | 418 / 18299 (2.3%) | 13843 / 182990 (7.6%) | −200.6 | −198.3 | 0.30 |
| FOXA1 SRX11222437 | MCF-7 Breast | 234 / 18299 (1.3%) | 10576 / 182990 (5.8%) | −200.3 | −198.0 | 0.22 |
| TEAD1 SRX3401272 | MCF-7 Breast | 247 / 18299 (1.3%) | 10806 / 182990 (5.9%) | −199.8 | −197.5 | 0.23 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1502 / 18299 (8.2%) | 5869 / 182990 (3.2%) | −199.7 | −197.5 | 2.56 |
| ESR1 SRX371467 | MCF-7 Breast | 385 / 18299 (2.1%) | 13247 / 182990 (7.2%) | −199.3 | −197.1 | 0.29 |
| FOXA1 SRX371480 | MCF-7 Breast | 229 / 18299 (1.3%) | 10448 / 182990 (5.7%) | −199.2 | −196.9 | 0.22 |
| ESR1 SRX20282954 | MCF-7 Breast | 395 / 18299 (2.2%) | 13390 / 182990 (7.3%) | −198.6 | −196.3 | 0.29 |
| ESR1 SRX371477 | MCF-7 Breast | 148 / 18299 (0.8%) | 8802 / 182990 (4.8%) | −198.2 | −196.0 | 0.17 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 842 / 18299 (4.6%) | 20251 / 182990 (11.1%) | −196.9 | −194.7 | 0.42 |
| ESR1 SRX20282972 | MCF-7 Breast | 411 / 18299 (2.2%) | 13600 / 182990 (7.4%) | −196.7 | −194.5 | 0.30 |
| JUN SRX6582172 | Fibroblasts Others | 472 / 18299 (2.6%) | 14579 / 182990 (8.0%) | −196.1 | −193.8 | 0.32 |
| FOXA1 SRX3931054 | MCF-7 Breast | 330 / 18299 (1.8%) | 12154 / 182990 (6.6%) | −194.8 | −192.6 | 0.27 |
| FOXA2 SRX3230382 | Hep G2 Liver | 488 / 18299 (2.7%) | 14792 / 182990 (8.1%) | −194.6 | −192.4 | 0.33 |
| AR SRX9469988 | LAPC-4 Prostate | 488 / 18299 (2.7%) | 14785 / 182990 (8.1%) | −194.5 | −192.3 | 0.33 |
| SSRP1 SRX3436567 | HT-1080 Bone | 464 / 18299 (2.5%) | 602 / 182990 (0.3%) | −194.4 | −192.2 | 7.71 |
| ESR1 SRX10365536 | MCF-7 Breast | 169 / 18299 (0.9%) | 9123 / 182990 (5.0%) | −194.2 | −192.0 | 0.19 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 892 / 18299 (4.9%) | 2455 / 182990 (1.3%) | −194.1 | −191.9 | 3.63 |
| ARID1A SRX5089376 | MCF-7 Breast | 308 / 18299 (1.7%) | 11742 / 182990 (6.4%) | −194.0 | −191.8 | 0.26 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1568 / 18299 (8.6%) | 6386 / 182990 (3.5%) | −193.9 | −191.7 | 2.46 |
| EP300 SRX100540 | SK-N-SH Neural | 518 / 18299 (2.8%) | 15242 / 182990 (8.3%) | −193.7 | −191.6 | 0.34 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 489 / 18299 (2.7%) | 14775 / 182990 (8.1%) | −193.6 | −191.4 | 0.33 |
| NR3C1 SRX2609666 | HASM2 Lung | 331 / 18299 (1.8%) | 12121 / 182990 (6.6%) | −193.1 | −191.0 | 0.27 |
| LEO1 SRX1873456 | SEM Blood | 1575 / 18299 (8.6%) | 6459 / 182990 (3.5%) | −192.4 | −190.2 | 2.44 |
| JUN SRX4192884 | MCF 10A Breast | 290 / 18299 (1.6%) | 11362 / 182990 (6.2%) | −192.1 | −189.9 | 0.26 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 274 / 18299 (1.5%) | 11070 / 182990 (6.0%) | −192.1 | −189.9 | 0.25 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 461 / 18299 (2.5%) | 14255 / 182990 (7.8%) | −191.7 | −189.5 | 0.32 |
| FOXA1 SRX3931055 | MCF-7 Breast | 299 / 18299 (1.6%) | 11500 / 182990 (6.3%) | −191.3 | −189.1 | 0.26 |
| SMARCA4 SRX5212371 | Mel270 Others | 517 / 18299 (2.8%) | 15142 / 182990 (8.3%) | −191.3 | −189.1 | 0.34 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 474 / 18299 (2.6%) | 14443 / 182990 (7.9%) | −191.0 | −188.8 | 0.33 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 240 / 18299 (1.3%) | 10407 / 182990 (5.7%) | −190.9 | −188.7 | 0.23 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 337 / 18299 (1.8%) | 12135 / 182990 (6.6%) | −190.2 | −188.1 | 0.28 |
| NR3C1 SRX2609661 | HASM2 Lung | 400 / 18299 (2.2%) | 13198 / 182990 (7.2%) | −190.1 | −187.9 | 0.30 |
| FOXA1 SRX11222441 | MCF-7 Breast | 268 / 18299 (1.5%) | 10887 / 182990 (5.9%) | −189.6 | −187.4 | 0.25 |
| FOXA1 SRX100506 | Hep G2 Liver | 487 / 18299 (2.7%) | 14600 / 182990 (8.0%) | −189.5 | −187.3 | 0.33 |
| ARID1A SRX5089379 | MCF-7 Breast | 359 / 18299 (2.0%) | 12483 / 182990 (6.8%) | −189.4 | −187.3 | 0.29 |
| ESR1 SRX10365535 | MCF-7 Breast | 290 / 18299 (1.6%) | 11272 / 182990 (6.2%) | −189.1 | −187.0 | 0.26 |
| SMARCA4 SRX5212357 | Mel270 Others | 536 / 18299 (2.9%) | 15362 / 182990 (8.4%) | −189.0 | −186.9 | 0.35 |
| AR SRX1067067 | LHSAR Prostate | 642 / 18299 (3.5%) | 16979 / 182990 (9.3%) | −188.5 | −186.3 | 0.38 |
| ARID5B SRX3230377 | Hep G2 Liver | 948 / 18299 (5.2%) | 21438 / 182990 (11.7%) | −188.3 | −186.2 | 0.44 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1476 / 18299 (8.1%) | 5903 / 182990 (3.2%) | −188.3 | −186.1 | 2.50 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 742 / 18299 (4.1%) | 18420 / 182990 (10.1%) | −187.1 | −184.9 | 0.40 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 247 / 18299 (1.3%) | 10420 / 182990 (5.7%) | −186.8 | −184.6 | 0.24 |
| YAP1 SRX10119364 | MCF 10A Breast | 295 / 18299 (1.6%) | 11277 / 182990 (6.2%) | −186.5 | −184.3 | 0.26 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 327 / 18299 (1.8%) | 11838 / 182990 (6.5%) | −186.4 | −184.3 | 0.28 |
| ESR1 SRX2943591 | MCF-7 Breast | 249 / 18299 (1.4%) | 10431 / 182990 (5.7%) | −186.1 | −183.9 | 0.24 |
| JUN SRX6582163 | BJ-5ta Epidermis | 460 / 18299 (2.5%) | 14048 / 182990 (7.7%) | −186.0 | −183.8 | 0.33 |
| FOXA1 SRX11222442 | MCF-7 Breast | 233 / 18299 (1.3%) | 10131 / 182990 (5.5%) | −185.9 | −183.8 | 0.23 |
| EP300 SRX2194265 | SUM 159PT Breast | 592 / 18299 (3.2%) | 16118 / 182990 (8.8%) | −185.8 | −183.6 | 0.37 |
| FOXA1 SRX5323843 | MCF-7 Breast | 167 / 18299 (0.9%) | 8841 / 182990 (4.8%) | −185.7 | −183.6 | 0.19 |
| FOXA1 SRX15430999 | T-47D Breast | 406 / 18299 (2.2%) | 13149 / 182990 (7.2%) | −185.5 | −183.4 | 0.31 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 400 / 18299 (2.2%) | 13043 / 182990 (7.1%) | −185.4 | −183.3 | 0.31 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 399 / 18299 (2.2%) | 13014 / 182990 (7.1%) | −185.0 | −182.9 | 0.31 |
| FOXA1 SRX1787652 | MCF-7 Breast | 208 / 18299 (1.1%) | 9625 / 182990 (5.3%) | −184.9 | −182.8 | 0.22 |
| TRP47 SRX4548329 | THP-1 Blood | 2747 / 18299 (15.0%) | 14877 / 182990 (8.1%) | −184.9 | −182.7 | 1.85 |
| CEBPB SRX2194250 | SUM 159PT Breast | 444 / 18299 (2.4%) | 13722 / 182990 (7.5%) | −184.1 | −181.9 | 0.32 |
| JUNB SRX4192882 | MCF 10A Breast | 287 / 18299 (1.6%) | 11053 / 182990 (6.0%) | −183.8 | −181.7 | 0.26 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 691 / 18299 (3.8%) | 17544 / 182990 (9.6%) | −183.8 | −181.6 | 0.39 |
| JUNB SRX10119386 | MCF 10A Breast | 329 / 18299 (1.8%) | 11787 / 182990 (6.4%) | −183.7 | −181.6 | 0.28 |
| TLE3 SRX4815192 | MCF-7 Breast | 335 / 18299 (1.8%) | 11877 / 182990 (6.5%) | −183.3 | −181.2 | 0.28 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 483 / 18299 (2.6%) | 14321 / 182990 (7.8%) | −183.1 | −181.0 | 0.34 |
| ESR1 SRX20282946 | MCF-7 Breast | 209 / 18299 (1.1%) | 9590 / 182990 (5.2%) | −183.1 | −181.0 | 0.22 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 654 / 18299 (3.6%) | 16951 / 182990 (9.3%) | −182.7 | −180.6 | 0.39 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 752 / 18299 (4.1%) | 18385 / 182990 (10.0%) | −182.1 | −180.0 | 0.41 |
| ESR1 SRX20282973 | MCF-7 Breast | 467 / 18299 (2.6%) | 14026 / 182990 (7.7%) | −182.0 | −179.9 | 0.33 |
| CEBPA SRX2630241 | Hep G2 Liver | 451 / 18299 (2.5%) | 13759 / 182990 (7.5%) | −181.7 | −179.6 | 0.33 |
| FOXA1 SRX028634 | MCF-7 Breast | 164 / 18299 (0.9%) | 8669 / 182990 (4.7%) | −181.7 | −179.6 | 0.19 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 509 / 18299 (2.8%) | 14682 / 182990 (8.0%) | −181.7 | −179.6 | 0.35 |
| ESR1 SRX10365532 | MCF-7 Breast | 188 / 18299 (1.0%) | 9138 / 182990 (5.0%) | −181.5 | −179.3 | 0.21 |
| JUNB SRX8488074 | SUM 229PE Breast | 504 / 18299 (2.8%) | 14592 / 182990 (8.0%) | −181.3 | −179.2 | 0.35 |
| NR2F2 SRX190293 | MCF-7 Breast | 401 / 18299 (2.2%) | 12921 / 182990 (7.1%) | −181.1 | −179.0 | 0.31 |
| KAT7 DRX234808 | 293 Kidney | 862 / 18299 (4.7%) | 2448 / 182990 (1.3%) | −180.5 | −178.4 | 3.52 |
| Epitope tags SRX10549777 | K-562 Blood | 2609 / 18299 (14.3%) | 13975 / 182990 (7.6%) | −180.2 | −178.1 | 1.87 |
| SOX13 SRX2636248 | Hep G2 Liver | 520 / 18299 (2.8%) | 14799 / 182990 (8.1%) | −180.0 | −177.9 | 0.35 |
| ESR1 SRX20282940 | MCF-7 Breast | 422 / 18299 (2.3%) | 13221 / 182990 (7.2%) | −179.8 | −177.7 | 0.32 |
| WWTR1 SRX10119378 | MCF 10A Breast | 403 / 18299 (2.2%) | 12894 / 182990 (7.0%) | −179.4 | −177.3 | 0.31 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 670 / 18299 (3.7%) | 1526 / 182990 (0.8%) | −178.8 | −176.7 | 4.39 |
| AR SRX1067066 | LHSAR Prostate | 827 / 18299 (4.5%) | 19344 / 182990 (10.6%) | −178.8 | −176.7 | 0.43 |
| FOXA1 SRX1787651 | MCF-7 Breast | 198 / 18299 (1.1%) | 9232 / 182990 (5.0%) | −178.1 | −176.1 | 0.21 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 320 / 18299 (1.7%) | 11442 / 182990 (6.3%) | −177.8 | −175.7 | 0.28 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 348 / 18299 (1.9%) | 11923 / 182990 (6.5%) | −177.8 | −175.7 | 0.29 |
| YAP1 SRX1038945 | IMR-90 Lung | 273 / 18299 (1.5%) | 10605 / 182990 (5.8%) | −177.5 | −175.4 | 0.26 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 605 / 18299 (3.3%) | 16016 / 182990 (8.8%) | −177.3 | −175.2 | 0.38 |
| FOXA2 SRX100448 | Hep G2 Liver | 421 / 18299 (2.3%) | 13118 / 182990 (7.2%) | −177.3 | −175.2 | 0.32 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 166 / 18299 (0.9%) | 8568 / 182990 (4.7%) | −176.9 | −174.8 | 0.19 |
| CDK9 SRX7366783 | MCF-7 Breast | 271 / 18299 (1.5%) | 137 / 182990 (0.1%) | −176.9 | −174.8 | 19.78 |
| JUNB SRX8488089 | SUM 229PE Breast | 385 / 18299 (2.1%) | 12511 / 182990 (6.8%) | −176.8 | −174.7 | 0.31 |
| ESR1 SRX371474 | BT-474 Breast | 158 / 18299 (0.9%) | 8392 / 182990 (4.6%) | −176.3 | −174.2 | 0.19 |
| FOXA1 SRX1787655 | MCF-7 Breast | 176 / 18299 (1.0%) | 8742 / 182990 (4.8%) | −176.1 | −174.0 | 0.20 |
| FOXA1 SRX3931033 | MCF-7 Breast | 231 / 18299 (1.3%) | 9780 / 182990 (5.3%) | −175.6 | −173.6 | 0.24 |
| ESR1 SRX2881002 | MCF-7 Breast | 367 / 18299 (2.0%) | 12166 / 182990 (6.6%) | −175.4 | −173.3 | 0.30 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1638 / 18299 (9.0%) | 7194 / 182990 (3.9%) | −175.4 | −173.3 | 2.28 |
| ESR1 SRX371475 | BT-474 Breast | 179 / 18299 (1.0%) | 8769 / 182990 (4.8%) | −175.0 | −172.9 | 0.20 |
| STAT3 SRX2020842 | HCC70 Breast | 691 / 18299 (3.8%) | 17218 / 182990 (9.4%) | −175.0 | −172.9 | 0.40 |
| NFIC SRX190336 | SK-N-SH Neural | 540 / 18299 (3.0%) | 14931 / 182990 (8.2%) | −174.8 | −172.8 | 0.36 |
| FOXA1 SRX11222438 | MCF-7 Breast | 190 / 18299 (1.0%) | 8979 / 182990 (4.9%) | −174.8 | −172.7 | 0.21 |
| FOXL2 SRX6957477 | KGN Gonad | 403 / 18299 (2.2%) | 12719 / 182990 (7.0%) | −174.0 | −172.0 | 0.32 |
| ESR1 SRX2881000 | MCF-7 Breast | 342 / 18299 (1.9%) | 11697 / 182990 (6.4%) | −174.0 | −171.9 | 0.29 |
| FOXA1 SRX3923517 | MCF-7 Breast | 266 / 18299 (1.5%) | 10366 / 182990 (5.7%) | −173.9 | −171.8 | 0.26 |
| ESR1 SRX20282955 | MCF-7 Breast | 420 / 18299 (2.3%) | 12985 / 182990 (7.1%) | −173.8 | −171.7 | 0.32 |
| STAT1 SRX23678708 | K-562 Blood | 1628 / 18299 (8.9%) | 7164 / 182990 (3.9%) | −173.5 | −171.4 | 2.27 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 359 / 18299 (2.0%) | 11964 / 182990 (6.5%) | −173.3 | −171.3 | 0.30 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 575 / 18299 (3.1%) | 15385 / 182990 (8.4%) | −172.6 | −170.5 | 0.37 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1136 / 18299 (6.2%) | 23393 / 182990 (12.8%) | −172.6 | −170.5 | 0.49 |
| GATAD2A SRX2636506 | Hep G2 Liver | 497 / 18299 (2.7%) | 14175 / 182990 (7.7%) | −172.4 | −170.4 | 0.35 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1414 / 18299 (7.7%) | 27072 / 182990 (14.8%) | −172.4 | −170.3 | 0.52 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 174 / 18299 (1.0%) | 8591 / 182990 (4.7%) | −172.3 | −170.2 | 0.20 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 635 / 18299 (3.5%) | 16282 / 182990 (8.9%) | −172.2 | −170.2 | 0.39 |
| FOXA1 SRX3923516 | MCF-7 Breast | 274 / 18299 (1.5%) | 10455 / 182990 (5.7%) | −172.1 | −170.1 | 0.26 |
| FOXA1 SRX1447317 | MCF-7 Breast | 244 / 18299 (1.3%) | 9905 / 182990 (5.4%) | −171.9 | −169.8 | 0.25 |
| GATA3 SRX6712581 | MCF-7 Breast | 318 / 18299 (1.7%) | 11217 / 182990 (6.1%) | −171.8 | −169.8 | 0.28 |
| EP300 SRX150579 | HeLa Uterus | 242 / 18299 (1.3%) | 9866 / 182990 (5.4%) | −171.7 | −169.6 | 0.25 |
| CDK9 SRX7366781 | MCF-7 Breast | 259 / 18299 (1.4%) | 125 / 182990 (0.1%) | −171.7 | −169.6 | 20.72 |
| FOXA1 SRX1961158 | T-47D Breast | 385 / 18299 (2.1%) | 12321 / 182990 (6.7%) | −171.0 | −169.0 | 0.31 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 496 / 18299 (2.7%) | 14089 / 182990 (7.7%) | −170.5 | −168.5 | 0.35 |
| ESR1 SRX10365533 | MCF-7 Breast | 172 / 18299 (0.9%) | 8493 / 182990 (4.6%) | −170.2 | −168.1 | 0.20 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 335 / 18299 (1.8%) | 11452 / 182990 (6.3%) | −170.1 | −168.0 | 0.29 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 271 / 18299 (1.5%) | 10335 / 182990 (5.6%) | −169.9 | −167.9 | 0.26 |
| FOXA1 SRX1961157 | T-47D Breast | 433 / 18299 (2.4%) | 13051 / 182990 (7.1%) | −169.5 | −167.4 | 0.33 |
| SMARCA4 SRX5075168 | Neural progenitor cells Neural | 555 / 18299 (3.0%) | 14958 / 182990 (8.2%) | −169.2 | −167.2 | 0.37 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 313 / 18299 (1.7%) | 11042 / 182990 (6.0%) | −169.1 | −167.1 | 0.28 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 565 / 18299 (3.1%) | 15105 / 182990 (8.3%) | −169.0 | −167.0 | 0.37 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 328 / 18299 (1.8%) | 11297 / 182990 (6.2%) | −169.0 | −167.0 | 0.29 |
| FOXA1 SRX028635 | MCF-7 Breast | 184 / 18299 (1.0%) | 8685 / 182990 (4.7%) | −168.8 | −166.7 | 0.21 |
| EP300 SRX176885 | MCF-7 Breast | 196 / 18299 (1.1%) | 8912 / 182990 (4.9%) | −168.7 | −166.7 | 0.22 |
| EP300 SRX1012648 | MCF-7 Breast | 172 / 18299 (0.9%) | 8447 / 182990 (4.6%) | −168.6 | −166.6 | 0.20 |
| NFYB SRX16608147 | HeLa Uterus | 291 / 18299 (1.6%) | 203 / 182990 (0.1%) | −168.4 | −166.3 | 14.34 |
| FOXA1 SRX3923518 | MCF-7 Breast | 265 / 18299 (1.4%) | 10167 / 182990 (5.6%) | −168.0 | −166.0 | 0.26 |
| ARID5B SRX10475139 | Hep G2 Liver | 421 / 18299 (2.3%) | 12807 / 182990 (7.0%) | −167.9 | −165.9 | 0.33 |
| ESR1 SRX1531796 | MCF-7 Breast | 197 / 18299 (1.1%) | 8906 / 182990 (4.9%) | −167.8 | −165.8 | 0.22 |
| FOXA1 SRX1161203 | T-47D Breast | 275 / 18299 (1.5%) | 10337 / 182990 (5.6%) | −167.8 | −165.8 | 0.27 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 413 / 18299 (2.3%) | 12671 / 182990 (6.9%) | −167.8 | −165.8 | 0.33 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 515 / 18299 (2.8%) | 14290 / 182990 (7.8%) | −167.8 | −165.8 | 0.36 |
| JUN SRX6582164 | BJ-5ta Epidermis | 501 / 18299 (2.7%) | 14064 / 182990 (7.7%) | −167.6 | −165.6 | 0.36 |
| FOXA1 SRX3931032 | MCF-7 Breast | 217 / 18299 (1.2%) | 9264 / 182990 (5.1%) | −167.2 | −165.2 | 0.23 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1683 / 18299 (9.2%) | 7666 / 182990 (4.2%) | −167.1 | −165.1 | 2.20 |
| STAT3 SRX150536 | MCF 10A Breast | 442 / 18299 (2.4%) | 13114 / 182990 (7.2%) | −167.1 | −165.1 | 0.34 |
| ESR1 SRX2943589 | MCF-7 Breast | 190 / 18299 (1.0%) | 8749 / 182990 (4.8%) | −166.9 | −164.9 | 0.22 |
| SMARCA4 SRX5716470 | Neural progenitor cells Neural | 321 / 18299 (1.8%) | 11101 / 182990 (6.1%) | −166.7 | −164.7 | 0.29 |
| Epitope tags SRX15939724 | RD Muscle | 334 / 18299 (1.8%) | 11325 / 182990 (6.2%) | −166.7 | −164.7 | 0.29 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 746 / 18299 (4.1%) | 17692 / 182990 (9.7%) | −166.3 | −164.3 | 0.42 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 356 / 18299 (1.9%) | 11668 / 182990 (6.4%) | −165.9 | −163.9 | 0.31 |
| ESR1 SRX330067 | MCF-7 Breast | 368 / 18299 (2.0%) | 11870 / 182990 (6.5%) | −165.9 | −163.9 | 0.31 |
| FOXA1 SRX100477 | Hep G2 Liver | 453 / 18299 (2.5%) | 13236 / 182990 (7.2%) | −165.5 | −163.5 | 0.34 |
| NKX2-1 SRX2164786 | A549 Lung | 665 / 18299 (3.6%) | 16476 / 182990 (9.0%) | −165.4 | −163.4 | 0.40 |
| NR3C1 SRX2609667 | HASM2 Lung | 392 / 18299 (2.1%) | 12244 / 182990 (6.7%) | −165.3 | −163.3 | 0.32 |
| NR3C1 SRX17639412 | A549 Lung | 446 / 18299 (2.4%) | 13116 / 182990 (7.2%) | −165.3 | −163.3 | 0.34 |
| FOXA1 SRX190282 | A549 Lung | 270 / 18299 (1.5%) | 10164 / 182990 (5.6%) | −165.1 | −163.1 | 0.27 |
| JADE3 DRX300415 | 293 Kidney | 1588 / 18299 (8.7%) | 7070 / 182990 (3.9%) | −164.9 | −162.9 | 2.25 |
| FOXA1 SRX5203303 | MCF-7 Breast | 118 / 18299 (0.6%) | 7224 / 182990 (3.9%) | −164.6 | −162.6 | 0.16 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 712 / 18299 (3.9%) | 17123 / 182990 (9.4%) | −164.2 | −162.3 | 0.42 |
| FOXA1 SRX3931056 | MCF-7 Breast | 227 / 18299 (1.2%) | 9360 / 182990 (5.1%) | −164.2 | −162.2 | 0.24 |
| FOXA1 SRX5323829 | T-47D Breast | 212 / 18299 (1.2%) | 9077 / 182990 (5.0%) | −164.0 | −162.0 | 0.23 |
| ESR1 SRX5323873 | MCF-7 Breast | 506 / 18299 (2.8%) | 14009 / 182990 (7.7%) | −163.9 | −161.9 | 0.36 |
| ESR1 SRX330070 | MCF-7 Breast | 201 / 18299 (1.1%) | 8865 / 182990 (4.8%) | −163.8 | −161.8 | 0.23 |
| FOXA1 SRX1447316 | MCF-7 Breast | 155 / 18299 (0.8%) | 7966 / 182990 (4.4%) | −163.7 | −161.7 | 0.19 |
| GATAD2A SRX2636507 | Hep G2 Liver | 429 / 18299 (2.3%) | 12786 / 182990 (7.0%) | −163.6 | −161.6 | 0.34 |
| CEBPB SRX150598 | IMR-90 Lung | 834 / 18299 (4.6%) | 18845 / 182990 (10.3%) | −163.5 | −161.5 | 0.44 |
| ESR1 SRX1012632 | MCF-7 Breast | 188 / 18299 (1.0%) | 8606 / 182990 (4.7%) | −163.5 | −161.5 | 0.22 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 338 / 18299 (1.8%) | 11283 / 182990 (6.2%) | −163.4 | −161.5 | 0.30 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 378 / 18299 (2.1%) | 11946 / 182990 (6.5%) | −163.3 | −161.4 | 0.32 |
| FOXA1 SRX3923519 | MCF-7 Breast | 239 / 18299 (1.3%) | 9549 / 182990 (5.2%) | −163.3 | −161.3 | 0.25 |
| AR SRX9109110 | MDA-MB-453 Breast | 767 / 18299 (4.2%) | 17881 / 182990 (9.8%) | −163.2 | −161.3 | 0.43 |
| PROX1 SRX3230397 | Hep G2 Liver | 280 / 18299 (1.5%) | 10280 / 182990 (5.6%) | −163.2 | −161.2 | 0.27 |
| ESR1 SRX3123829 | MCF-7 Breast | 224 / 18299 (1.2%) | 9269 / 182990 (5.1%) | −163.1 | −161.1 | 0.24 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 258 / 18299 (1.4%) | 9875 / 182990 (5.4%) | −162.7 | −160.7 | 0.26 |
| ESR1 SRX1012629 | MCF-7 Breast | 248 / 18299 (1.4%) | 9697 / 182990 (5.3%) | −162.7 | −160.7 | 0.26 |
| ESR1 SRX4367192 | MCF-7 Breast | 856 / 18299 (4.7%) | 19117 / 182990 (10.4%) | −162.6 | −160.6 | 0.45 |
| FOXA1 SRX3923515 | MCF-7 Breast | 217 / 18299 (1.2%) | 9126 / 182990 (5.0%) | −162.5 | −160.6 | 0.24 |
| JUN SRX6582165 | BJ-5ta Epidermis | 780 / 18299 (4.3%) | 18035 / 182990 (9.9%) | −162.5 | −160.6 | 0.43 |
| FOXA1 SRX190181 | A549 Lung | 285 / 18299 (1.6%) | 10341 / 182990 (5.7%) | −162.4 | −160.4 | 0.28 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1632 / 18299 (8.9%) | 7424 / 182990 (4.1%) | −162.3 | −160.3 | 2.20 |
| ESR1 SRX10365558 | MCF-7 Breast | 269 / 18299 (1.5%) | 10058 / 182990 (5.5%) | −162.3 | −160.3 | 0.27 |
| FOXA2 SRX10475773 | Hep G2 Liver | 491 / 18299 (2.7%) | 13715 / 182990 (7.5%) | −162.1 | −160.1 | 0.36 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 729 / 18299 (4.0%) | 17284 / 182990 (9.4%) | −162.1 | −160.1 | 0.42 |
| FOXA1 SRX6878603 | LNCAP Prostate | 451 / 18299 (2.5%) | 13079 / 182990 (7.1%) | −162.0 | −160.0 | 0.34 |
| STAT3 SRX150479 | MCF 10A Breast | 379 / 18299 (2.1%) | 11914 / 182990 (6.5%) | −161.9 | −160.0 | 0.32 |
| ESR1 SRX3110725 | MCF-7 Breast | 371 / 18299 (2.0%) | 11782 / 182990 (6.4%) | −161.8 | −159.8 | 0.31 |
| EP300 ERX626811 | U-937 Blood | 1293 / 18299 (7.1%) | 5210 / 182990 (2.8%) | −161.7 | −159.8 | 2.48 |
| MITF SRX7368256 | Hermes 3C Epidermis | 805 / 18299 (4.4%) | 18358 / 182990 (10.0%) | −161.6 | −159.6 | 0.44 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1678 / 18299 (9.2%) | 7751 / 182990 (4.2%) | −161.5 | −159.5 | 2.16 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 393 / 18299 (2.1%) | 12130 / 182990 (6.6%) | −161.4 | −159.5 | 0.32 |
| ESR1 SRX20282971 | MCF-7 Breast | 411 / 18299 (2.2%) | 12416 / 182990 (6.8%) | −161.3 | −159.4 | 0.33 |
| SREBF2 SRX5359048 | HCC70 Breast | 1743 / 18299 (9.5%) | 8204 / 182990 (4.5%) | −161.3 | −159.4 | 2.12 |
| RBFOX2 SRX4708082 | K-562 Blood | 2463 / 18299 (13.5%) | 13424 / 182990 (7.3%) | −161.0 | −159.1 | 1.83 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 391 / 18299 (2.1%) | 12079 / 182990 (6.6%) | −160.9 | −158.9 | 0.32 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 427 / 18299 (2.3%) | 12662 / 182990 (6.9%) | −160.9 | −158.9 | 0.34 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 261 / 18299 (1.4%) | 9868 / 182990 (5.4%) | −160.8 | −158.8 | 0.26 |
| ESR1 SRX330069 | MCF-7 Breast | 248 / 18299 (1.4%) | 9637 / 182990 (5.3%) | −160.8 | −158.8 | 0.26 |
| EP300 ERX626821 | U-937 Blood | 1287 / 18299 (7.0%) | 5189 / 182990 (2.8%) | −160.7 | −158.8 | 2.48 |
| FOXA1 SRX1161205 | T-47D Breast | 203 / 18299 (1.1%) | 8799 / 182990 (4.8%) | −160.5 | −158.5 | 0.23 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 452 / 18299 (2.5%) | 13021 / 182990 (7.1%) | −159.8 | −157.9 | 0.35 |
| ESR1 SRX20282953 | MCF-7 Breast | 337 / 18299 (1.8%) | 11149 / 182990 (6.1%) | −159.8 | −157.8 | 0.30 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1686 / 18299 (9.2%) | 7845 / 182990 (4.3%) | −159.7 | −157.8 | 2.15 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 720 / 18299 (3.9%) | 17063 / 182990 (9.3%) | −159.7 | −157.8 | 0.42 |
| AR SRX9109113 | MDA-MB-453 Breast | 794 / 18299 (4.3%) | 18121 / 182990 (9.9%) | −159.5 | −157.6 | 0.44 |
| MECOM SRX23677885 | HNT-34 Blood | 1815 / 18299 (9.9%) | 8746 / 182990 (4.8%) | −159.5 | −157.6 | 2.08 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 521 / 18299 (2.8%) | 14084 / 182990 (7.7%) | −159.4 | −157.5 | 0.37 |
| EP300 SRX190219 | SK-N-SH Neural | 396 / 18299 (2.2%) | 12111 / 182990 (6.6%) | −159.4 | −157.5 | 0.33 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 922 / 18299 (5.0%) | 3026 / 182990 (1.7%) | −159.4 | −157.4 | 3.05 |
| ESR1 SRX20282938 | MCF-7 Breast | 330 / 18299 (1.8%) | 11013 / 182990 (6.0%) | −159.3 | −157.4 | 0.30 |
| ARID1A SRX5089391 | MCF-7 Breast | 221 / 18299 (1.2%) | 9097 / 182990 (5.0%) | −159.3 | −157.3 | 0.24 |
| ARID5B SRX10475138 | Hep G2 Liver | 684 / 18299 (3.7%) | 16508 / 182990 (9.0%) | −158.9 | −157.0 | 0.41 |
| STAT3 SRX150630 | MCF 10A Breast | 381 / 18299 (2.1%) | 11843 / 182990 (6.5%) | −158.8 | −156.9 | 0.32 |
| ESR1 SRX20282959 | MCF-7 Breast | 158 / 18299 (0.9%) | 7880 / 182990 (4.3%) | −158.7 | −156.8 | 0.20 |
| JUN SRX883584 | MDA-MB-231 Breast | 659 / 18299 (3.6%) | 16135 / 182990 (8.8%) | −158.7 | −156.8 | 0.41 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 133 / 18299 (0.7%) | 7370 / 182990 (4.0%) | −158.5 | −156.6 | 0.18 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 557 / 18299 (3.0%) | 14602 / 182990 (8.0%) | −158.5 | −156.6 | 0.38 |
| CEBPA SRX4705113 | MOLM-13 Blood | 962 / 18299 (5.3%) | 20426 / 182990 (11.2%) | −158.5 | −156.5 | 0.47 |
| JUNB SRX10119383 | MCF 10A Breast | 278 / 18299 (1.5%) | 10092 / 182990 (5.5%) | −158.3 | −156.4 | 0.28 |
| NR3C1 SRX2609668 | HASM2 Lung | 307 / 18299 (1.7%) | 10591 / 182990 (5.8%) | −158.3 | −156.4 | 0.29 |
| STAT1 SRX23678707 | K-562 Blood | 1494 / 18299 (8.2%) | 6578 / 182990 (3.6%) | −158.3 | −156.4 | 2.27 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1171 / 18299 (6.4%) | 4509 / 182990 (2.5%) | −158.2 | −156.3 | 2.60 |
| ESR1 SRX4451213 | MCF-7 Breast | 428 / 18299 (2.3%) | 12575 / 182990 (6.9%) | −158.0 | −156.1 | 0.34 |
| ARID1A SRX5089385 | MCF-7 Breast | 308 / 18299 (1.7%) | 10598 / 182990 (5.8%) | −158.0 | −156.1 | 0.29 |
| Epitope tags SRX2745846 | MCF 10A Breast | 257 / 18299 (1.4%) | 9709 / 182990 (5.3%) | −157.9 | −156.0 | 0.26 |
| JUN SRX7277180 | GM07492 Others | 337 / 18299 (1.8%) | 11078 / 182990 (6.1%) | −157.7 | −155.8 | 0.30 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 270 / 18299 (1.5%) | 9924 / 182990 (5.4%) | −157.6 | −155.7 | 0.27 |
| ARID1A SRX5089382 | MCF-7 Breast | 291 / 18299 (1.6%) | 10288 / 182990 (5.6%) | −157.5 | −155.6 | 0.28 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 506 / 18299 (2.8%) | 13784 / 182990 (7.5%) | −157.5 | −155.6 | 0.37 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1871 / 18299 (10.2%) | 9192 / 182990 (5.0%) | −157.4 | −155.5 | 2.04 |
| TEAD1 SRX716558 | SF268 Neural | 201 / 18299 (1.1%) | 8664 / 182990 (4.7%) | −157.2 | −155.3 | 0.23 |
| VGLL1 SRX18013277 | FULVR Breast | 167 / 18299 (0.9%) | 7995 / 182990 (4.4%) | −156.5 | −154.6 | 0.21 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 384 / 18299 (2.1%) | 11798 / 182990 (6.4%) | −156.0 | −154.1 | 0.33 |
| JUND SRX150408 | HeLa Uterus | 367 / 18299 (2.0%) | 11521 / 182990 (6.3%) | −156.0 | −154.1 | 0.32 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 390 / 18299 (2.1%) | 11892 / 182990 (6.5%) | −156.0 | −154.1 | 0.33 |
| HMG20A SRX2630163 | Hep G2 Liver | 220 / 18299 (1.2%) | 8973 / 182990 (4.9%) | −155.8 | −153.9 | 0.25 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 425 / 18299 (2.3%) | 12443 / 182990 (6.8%) | −155.6 | −153.7 | 0.34 |
| ESR1 SRX1469949 | MCF-7 Breast | 236 / 18299 (1.3%) | 9252 / 182990 (5.1%) | −155.5 | −153.6 | 0.26 |
| ARID1A SRX5089388 | MCF-7 Breast | 208 / 18299 (1.1%) | 8739 / 182990 (4.8%) | −155.4 | −153.5 | 0.24 |
| CEBPB SRX190345 | MCF-7 Breast | 321 / 18299 (1.8%) | 10727 / 182990 (5.9%) | −155.2 | −153.3 | 0.30 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 593 / 18299 (3.2%) | 15015 / 182990 (8.2%) | −155.0 | −153.1 | 0.39 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 495 / 18299 (2.7%) | 13504 / 182990 (7.4%) | −154.4 | −152.5 | 0.37 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 900 / 18299 (4.9%) | 2969 / 182990 (1.6%) | −154.3 | −152.4 | 3.03 |
| ESR1 SRX5323871 | MCF-7 Breast | 465 / 18299 (2.5%) | 13020 / 182990 (7.1%) | −154.0 | −152.2 | 0.36 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 647 / 18299 (3.5%) | 15774 / 182990 (8.6%) | −153.9 | −152.0 | 0.41 |
| FOXA1 SRX5203294 | MCF-7 Breast | 105 / 18299 (0.6%) | 6643 / 182990 (3.6%) | −153.8 | −151.9 | 0.16 |
| FOXA1 SRX5323830 | T-47D Breast | 238 / 18299 (1.3%) | 9235 / 182990 (5.0%) | −153.7 | −151.8 | 0.26 |
| FOXA1 SRX5203307 | MCF-7 Breast | 108 / 18299 (0.6%) | 6709 / 182990 (3.7%) | −153.7 | −151.8 | 0.16 |
| FOXA1 SRX3931031 | MCF-7 Breast | 189 / 18299 (1.0%) | 8332 / 182990 (4.6%) | −153.7 | −151.8 | 0.23 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 310 / 18299 (1.7%) | 10486 / 182990 (5.7%) | −153.5 | −151.7 | 0.30 |
| MEN1 SRX11712604 | K-562 Blood | 1460 / 18299 (8.0%) | 6451 / 182990 (3.5%) | −153.5 | −151.6 | 2.26 |
| ESR1 SRX1012633 | MCF-7 Breast | 211 / 18299 (1.2%) | 8732 / 182990 (4.8%) | −153.3 | −151.4 | 0.24 |
| PGR SRX1012655 | MCF-7 Breast | 266 / 18299 (1.5%) | 9711 / 182990 (5.3%) | −153.1 | −151.2 | 0.27 |
| FOSL2 SRX190204 | A549 Lung | 419 / 18299 (2.3%) | 12259 / 182990 (6.7%) | −153.1 | −151.2 | 0.34 |
| CEBPB SRX2194249 | SUM 159PT Breast | 407 / 18299 (2.2%) | 12065 / 182990 (6.6%) | −152.9 | −151.0 | 0.34 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 833 / 18299 (4.6%) | 2617 / 182990 (1.4%) | −152.9 | −151.0 | 3.18 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 269 / 18299 (1.5%) | 9756 / 182990 (5.3%) | −152.8 | −151.0 | 0.28 |
| JADE3 DRX234809 | 293 Kidney | 1057 / 18299 (5.8%) | 3906 / 182990 (2.1%) | −152.7 | −150.8 | 2.71 |
| FOXA1 SRX6860635 | T-47D Breast | 316 / 18299 (1.7%) | 10559 / 182990 (5.8%) | −152.6 | −150.8 | 0.30 |
| NANOG SRX10445309 | Neural crest cells Neural | 227 / 18299 (1.2%) | 8998 / 182990 (4.9%) | −152.5 | −150.6 | 0.25 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1017 / 18299 (5.6%) | 20922 / 182990 (11.4%) | −152.4 | −150.5 | 0.49 |
| ESR1 SRX8537722 | MCF-7 Breast | 401 / 18299 (2.2%) | 11946 / 182990 (6.5%) | −152.3 | −150.4 | 0.34 |
| SS18 SRX10881848 | G-401 Kidney | 566 / 18299 (3.1%) | 14501 / 182990 (7.9%) | −152.1 | −150.3 | 0.39 |
| MECOM SRX23677884 | HNT-34 Blood | 1767 / 18299 (9.7%) | 8584 / 182990 (4.7%) | −152.0 | −150.1 | 2.06 |
| ESR1 SRX2912055 | MCF-7 Breast | 155 / 18299 (0.8%) | 7621 / 182990 (4.2%) | −152.0 | −150.1 | 0.20 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 230 / 18299 (1.3%) | 9032 / 182990 (4.9%) | −151.9 | −150.0 | 0.25 |
| WWTR1 SRX10119368 | MCF 10A Breast | 290 / 18299 (1.6%) | 10079 / 182990 (5.5%) | −151.5 | −149.7 | 0.29 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 318 / 18299 (1.7%) | 10550 / 182990 (5.8%) | −151.5 | −149.6 | 0.30 |
| FOXA1 SRX1161207 | T-47D Breast | 162 / 18299 (0.9%) | 7742 / 182990 (4.2%) | −151.4 | −149.5 | 0.21 |
| NR3C1 SRX10976921 | A549 Lung | 297 / 18299 (1.6%) | 10191 / 182990 (5.6%) | −151.3 | −149.4 | 0.29 |
| FOXA1 SRX5323846 | MCF-7 Breast | 149 / 18299 (0.8%) | 7478 / 182990 (4.1%) | −151.1 | −149.2 | 0.20 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 612 / 18299 (3.3%) | 15149 / 182990 (8.3%) | −151.0 | −149.2 | 0.40 |
| JUNB SRX10119384 | MCF 10A Breast | 253 / 18299 (1.4%) | 9416 / 182990 (5.1%) | −151.0 | −149.1 | 0.27 |
| MITF SRX1555436 | 501A Epidermis | 1997 / 18299 (10.9%) | 10254 / 182990 (5.6%) | −150.9 | −149.1 | 1.95 |
| ESR1 SRX330068 | MCF-7 Breast | 193 / 18299 (1.1%) | 8323 / 182990 (4.5%) | −150.9 | −149.1 | 0.23 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 523 / 18299 (2.9%) | 13801 / 182990 (7.5%) | −150.8 | −149.0 | 0.38 |
| EP300 SRX22550927 | CDS1 Bone | 637 / 18299 (3.5%) | 15507 / 182990 (8.5%) | −150.8 | −148.9 | 0.41 |
| TP53 SRX19538272 | U2OS Bone | 555 / 18299 (3.0%) | 1241 / 182990 (0.7%) | −150.7 | −148.8 | 4.47 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 450 / 18299 (2.5%) | 12665 / 182990 (6.9%) | −150.6 | −148.7 | 0.36 |
| GATA3 SRX5457550 | MCF-7 Breast | 490 / 18299 (2.7%) | 13286 / 182990 (7.3%) | −150.6 | −148.7 | 0.37 |
| ESR1 SRX5323878 | MCF-7 Breast | 432 / 18299 (2.4%) | 12376 / 182990 (6.8%) | −150.5 | −148.6 | 0.35 |
| KAT7 DRX300414 | 293 Kidney | 652 / 18299 (3.6%) | 1701 / 182990 (0.9%) | −150.4 | −148.6 | 3.83 |
| SOX5 SRX2636544 | Hep G2 Liver | 416 / 18299 (2.3%) | 12118 / 182990 (6.6%) | −150.4 | −148.6 | 0.34 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1953 / 18299 (10.7%) | 9953 / 182990 (5.4%) | −150.3 | −148.5 | 1.96 |
| ZEB1 SRX13298925 | MCF-7 Breast | 260 / 18299 (1.4%) | 9516 / 182990 (5.2%) | −150.2 | −148.4 | 0.27 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 291 / 18299 (1.6%) | 10051 / 182990 (5.5%) | −150.2 | −148.4 | 0.29 |
| FOXA1 SRX5323845 | MCF-7 Breast | 147 / 18299 (0.8%) | 7409 / 182990 (4.0%) | −150.1 | −148.2 | 0.20 |
| RELA SRX7055007 | HAEC Cardiovascular | 769 / 18299 (4.2%) | 17375 / 182990 (9.5%) | −149.9 | −148.0 | 0.44 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 372 / 18299 (2.0%) | 11390 / 182990 (6.2%) | −149.8 | −147.9 | 0.33 |
| Epitope tags SRX5877912 | U2OS Bone | 2345 / 18299 (12.8%) | 37543 / 182990 (20.5%) | −149.7 | −147.8 | 0.62 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1751 / 18299 (9.6%) | 8530 / 182990 (4.7%) | −149.7 | −147.8 | 2.05 |
| SSRP1 SRX3436566 | HT-1080 Bone | 336 / 18299 (1.8%) | 395 / 182990 (0.2%) | −149.7 | −147.8 | 8.51 |
| NR3C1 SRX10977357 | A549 Lung | 262 / 18299 (1.4%) | 9523 / 182990 (5.2%) | −149.4 | −147.6 | 0.28 |
| TFAP2C SRX018833 | MCF-7 Breast | 394 / 18299 (2.2%) | 11715 / 182990 (6.4%) | −149.0 | −147.1 | 0.34 |
| NR3C1 SRX19024866 | MCF-7 Breast | 140 / 18299 (0.8%) | 7236 / 182990 (4.0%) | −148.9 | −147.0 | 0.19 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 464 / 18299 (2.5%) | 12818 / 182990 (7.0%) | −148.7 | −146.9 | 0.36 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 677 / 18299 (3.7%) | 1843 / 182990 (1.0%) | −148.7 | −146.9 | 3.67 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 230 / 18299 (1.3%) | 120 / 182990 (0.1%) | −148.6 | −146.8 | 19.17 |
| EP300 SRX100544 | Hep G2 Liver | 316 / 18299 (1.7%) | 10424 / 182990 (5.7%) | −148.6 | −146.7 | 0.30 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 707 / 18299 (3.9%) | 2000 / 182990 (1.1%) | −148.3 | −146.5 | 3.54 |
| ESR1 SRX8537723 | MCF-7 Breast | 349 / 18299 (1.9%) | 10960 / 182990 (6.0%) | −148.2 | −146.4 | 0.32 |
| FOS SRX3322636 | MCF-7 Breast | 283 / 18299 (1.5%) | 9848 / 182990 (5.4%) | −148.1 | −146.3 | 0.29 |
| TEAD4 SRX190301 | hESC H1 Pluripotent stem cell | 305 / 18299 (1.7%) | 10218 / 182990 (5.6%) | −148.1 | −146.2 | 0.30 |
| FOXA1 SRX1787654 | MCF-7 Breast | 149 / 18299 (0.8%) | 7390 / 182990 (4.0%) | −148.0 | −146.2 | 0.20 |
| TFAP2C SRX128099 | MCF-7 Breast | 395 / 18299 (2.2%) | 11696 / 182990 (6.4%) | −147.9 | −146.0 | 0.34 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 357 / 18299 (2.0%) | 11078 / 182990 (6.1%) | −147.8 | −146.0 | 0.32 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 273 / 18299 (1.5%) | 9658 / 182990 (5.3%) | −147.6 | −145.8 | 0.28 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 362 / 18299 (2.0%) | 11151 / 182990 (6.1%) | −147.6 | −145.8 | 0.32 |
| JUN SRX2355072 | HAEC Cardiovascular | 569 / 18299 (3.1%) | 14373 / 182990 (7.9%) | −147.5 | −145.6 | 0.40 |
| RUNX1 SRX10119135 | MV-4-11 Blood | 467 / 18299 (2.6%) | 12818 / 182990 (7.0%) | −147.4 | −145.6 | 0.36 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 109 / 18299 (0.6%) | 6551 / 182990 (3.6%) | −147.4 | −145.5 | 0.17 |
| FOS SRX070879 | HUVEC Cardiovascular | 458 / 18299 (2.5%) | 12664 / 182990 (6.9%) | −147.1 | −145.3 | 0.36 |
| EP300 SRX1012644 | MCF-7 Breast | 192 / 18299 (1.0%) | 8187 / 182990 (4.5%) | −147.1 | −145.3 | 0.23 |
| JUN SRX2355073 | HAEC Cardiovascular | 545 / 18299 (3.0%) | 13990 / 182990 (7.6%) | −146.8 | −145.0 | 0.39 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 591 / 18299 (3.2%) | 14671 / 182990 (8.0%) | −146.7 | −144.9 | 0.40 |
| NFIL3 SRX2630334 | Hep G2 Liver | 338 / 18299 (1.8%) | 10722 / 182990 (5.9%) | −146.5 | −144.7 | 0.32 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 541 / 18299 (3.0%) | 1215 / 182990 (0.7%) | −146.2 | −144.4 | 4.45 |
| ESR1 SRX20282966 | MCF-7 Breast | 148 / 18299 (0.8%) | 7313 / 182990 (4.0%) | −146.1 | −144.3 | 0.20 |
| ESR1 SRX2513521 | MCF-7 Breast | 201 / 18299 (1.1%) | 8316 / 182990 (4.5%) | −145.8 | −144.0 | 0.24 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1917 / 18299 (10.5%) | 9813 / 182990 (5.4%) | −145.7 | −143.9 | 1.95 |
| FOXO1 SRX1048948 | Endometrial stromal cells Uterus | 207 / 18299 (1.1%) | 8420 / 182990 (4.6%) | −145.5 | −143.7 | 0.25 |
Showing first 500 of 18010 rows.